290 results on '"Manesis E."'
Search Results
2. Correction to: Keratin 7 expression in hepatic cholestatic diseases
3. INVESTIGATION OF LIVER FAT MASS AND FAT FRACTION RELATIONSHIPS WITH LIVER VOLUME, USING PDFF MRI IN NALFD PATIENTS
4. Complex liver injury induced by combined Aloe Vera and vitamin A oral supplements, as assessed by histology and the updated RUCAM
5. Hepatocellular carcinoma risk in HBeAg-negative chronic hepatitis B patients with or without cirrhosis treated with entecavir: HepNet.Greece cohort
6. Keratin 7 expression in hepatic cholestatic diseases
7. Keratin 7 expression in hepatic cholestatic diseases (Jul, 10.1007/s00428-021-03152-z, 2021)
8. Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers
9. Development and assessment of a novel real-time PCR assay for quantitation of hepatitis D virus RNA to study viral kinetics in chronic hepatitis D
10. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C
11. Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
12. Serum HCV RNA levels and HCV genotype do not affect insulin resistance in nondiabetic patients with chronic hepatitis C: a multicentre study
13. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study
14. Natural course of treated and untreated chronic HCV infection: results of the nationwide Hepnet.Greece cohort study
15. Epidemiology, course and disease burden of chronic hepatitis B virus infection. HEPNET study for chronic hepatitis B: a multicentre Greek study
16. Longitudinal changes in serum HBV DNA levels and predictors of progression during the natural course of HBeAg-negative chronic hepatitis B virus infection
17. Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection
18. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis
19. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis
20. A partially overlapping treatment course with lamivudine and interferon in hepatitis B e antigen-negative chronic hepatitis B
21. Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B
22. Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole
23. Induction interferon therapy in naïve patients with chronic hepatitis C: increased end-of-treatment virological responses but absence of long-term benefit
24. Interferon treatment with or without oral ganciclovir in HBeAg-negative chronic hepatitis B: a randomized study
25. C01/87 THYROID ABNORMALITIES IN CHRONIC VIRAL HEPATITIS AND ITS RELATIONSHIP TO ALPHA-INTERFERON THERAPY
26. P2.34 The Presence of Cirrhosis Ameliorates the Arterial Stiffness in Patients with Non-Alcoholic Steatohepatitis
27. Platelets represent an independent predictor of sustained virological response (SVR) in patients with advanced chronic hepatitis C (CHC) treated with current direct acting antiviral(s) (DAA). HERACLIS: Hellenic multicenter real-life cohort study
28. Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study
29. P.051 Arterial Stiffness is Increased in Patients with Hepatitis C Virus Seropositivity, But Not in Patients with Hepatitis B Virus Seropositivity and the Role of Leptin
30. Impact of Safety-Related Dose Reductions or Discontinuations on Sustained Virologic Response in HCV-Infected Patients: Results from the GUARD-C Cohort
31. P2.32 Non Alcoholic Fatty Liver is Related to Impaired Arterial Function and Subclinical Atherosclerosis
32. P2.33 Adiponectin Hormone, Hypertension and Endothelial Dysfunction in Non-Alcoholic Fatty Liver Disease Patients
33. 06.04 Non-Alcoholic Fatty Liver Disease is Associated with Impaired Secretion of Fat Produced Hormones and Increased Cardiovascular Risk
34. P.028 Non-Alcoholic Fatty Liver Disease is Associated with Increased Aortic Stiffness and Carotid Intima Media Thickness
35. P.027 Aortic Stiffness is Increased in Patients with Hepatitis C Virus Seropositivity
36. Platelets represent an independent predictor of sustained virological response (SVR) in patients with advanced chronic hepatitis C (CHC) treated with current direct acting antiviral(s) (DAA). HERACLIS: Hellenic multicenter real-life cohort study
37. 2D-SHEAR WAVE ELASTOGRAPHY IS EQUIVALENT OR SUPERIOR TO TRANSIENT ELASTOGRAPHY FOR LIVER FIBROSIS ASSESSMENT: RESULTS FROM AN INDIVIDUAL PATIENT DATA BASED META-ANALYSIS
38. Diffractive one-particle inclusive distribution and pomeron-proton total cross-section
39. Pomeron-pomeron total cross-section and the reaction pp → pXp
40. Elastic stability of conservative systems: A new approach
41. Integral equations for hadronic correlation functions: A functional-bootstrap approach
42. Double-pomeron exchange cross-sections with a central 2π vertex
43. Ultrasensitive amplification refractory mutation system real-time PCR (ARMS RT-PCR) assay for detection of minority Hepatitis B virus-resistant strains in the era of personalized medicine
44. HEPATOCELLULAR CARCINOMA (HCC) RISK IN HBeAg-NEGATIVE CHRONIC HEPATITIS B (CHBe-) WITH OR WITHOUT CIRRHOSIS TREATED WITH ENTECAVIR: RESULTS OF THE NATIONWIDE HepNet.Greece COHORT STUDY
45. High-energy nucleon-nucleon charge exchange scattering in a weak-cut model
46. DETECTION OF MINORITY HBV RESISTANT STRAINS IN HBV TREATMENT NAIVE PATIENTS USING A HIGHLY SENSITIVE ASSAY BASED ON ARMS RT-PCR WITH MOLECULAR BEACON
47. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C
48. Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection
49. Quantitative detection of the M204V hepatitis B virus minor variants by amplification refractory mutation system real-time PCR combined with molecular beacon technology
50. Prevalence of glucose intolerance in patients with chronic hepatitis B or C: a prospective case-control study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.